ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

ADMA Biologics faces a securities class action lawsuit for allegedly failing to disclose material information between August 2024 and March 2026. The company is accused of undisclosed related party transactions, channel stuffing, inadequate internal controls, and making false statements about its business operations and prospects. Investors with losses exceeding $100,000 have until August 10, 2026 to file lead plaintiff applications.